Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes
作者:Cem Yamali、Halise Inci Gul、Abdulilah Ece、Parham Taslimi、Ilhami Gulcin
DOI:10.1111/cbdd.13149
日期:2018.4
In this study, 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides were synthesized, and inhibition effects on AChE, hCA I, and hCA II were evaluated. Ki values of the compounds toward hCA I were in the range of 24.2 ± 4.6‐49.8 ± 12.8 nm, while they were in the range of 37.3 ± 9.0‐65.3 ± 16.7 nm toward hCA II. Ki values of the acetazolamide were 282.1 ± 19.7 nm and 103.60 ± 27
在这项研究中,合成了4- [5-芳基-3-(噻吩-2-基)-4,5-二氢-1 H-吡唑-1-基]苯磺酰胺,并对AChE,hCA I和AChE具有抑制作用。 hCA II进行了评估。朝向hCA I的化合物的K i值在24.2±4.6-49.8±12.8 n m的范围内,而朝向hCA II的K i值在37.3±9.0-65.3±16.7 n m的范围内。两种同工酶的乙酰唑酰胺的K i值分别为282.1±19.7 n m和103.60±27.6 n m。化合物抑制的AChE与ķ我在22.7±10.3-109.1±27.0 n中的范围米,而他克林具有ķi值为66.5±13.8 n m。还进行了M06-L / 6-31 + G(d,p)// AM1水平的电子结构计算和分子对接研究,以启发抑制机理并支持实验结果。通过分子特性计算获得的结果表明,这些化合物符合药物样特性。在这项研究中获得的实验和计算结果可能有助于设计针对hCA